when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Hematology · news · pharmadog

← back to Hematology

News · Hematology

411 stories

Jun 18, 26How many Americans can afford high-quality health care? A new poll finds the number has fallenstat

Jun 18, 26Kardigan extends biotech’s streak of big IPOs with $400M haulbiopharma dive

Jun 17, 26Jazz zeroes in on next-gen T cell engagers with AbCellera dealbiopharma dive

Jun 17, 26A new Westlake-backed biotech takes aim at migrainesbiopharma dive

Jun 16, 26STAT+: How a biotech turned a trial failure into an AI modelstat

Jun 16, 26Edgewise heart drug passes key trial testbiopharma dive

Jun 16, 26How supplement use changed over decadesstat

Jun 16, 26Opinion: I’m an Alzheimer’s specialist. I still missed it in my own fatherstat

Jun 15, 26FDA Approves New Indication for Tzield (teplizumab) for Certain Pediatric Patients with Recently Diagnosed Stage 3 Type 1 Diabetesfda press

Jun 15, 26Lilly scores early positive data for new JAK drugbiopharma dive

Jun 15, 26J&J multiple myeloma drug gains edge in earlier stage diseasebiopharma dive

Jun 15, 26Lilly puts its stamp at #EHA26 with Jaypirca combo data in CLL, first clinical data from Ajax buyoutendpoints

Jun 12, 26FDA Clears First Over-the-Counter Continuous Glucose Monitor for Childrenfda press

Jun 12, 26STAT+: Prometheus raises $12 billion in capital for artificial engineersstat

Jun 12, 26STAT+: Pharmalittle: We’re reading about a discontinued cancer drug, a Novo security breach, and morestat

Jun 11, 26STAT+: AMA and lawmakers push back on AI care denialsstat

Jun 11, 26Nonprofit buys experimental cancer drug to maintain patient accessstat

Jun 11, 26Study highlights influence of socioeconomic status on children’s brain developmentstat

Jun 11, 26J&J looks to widen Imaavy’s use; $300M backs rare disease drug launchbiopharma dive

Jun 11, 26Opinion: How long Covid’s scientific stalemate made it politically erasablestat

Jun 10, 26AstraZeneca’s ‘extensive’ obesity drug push; $125M for ultrasound-aided genetic medicinebiopharma dive

Jun 9, 26Trump administration warns more than 500 hospitals to provide more price information or face finesstat

Jun 9, 26Gilead and Merck’s latest trial success and flopstat

Jun 9, 26Dexcom RCT suggests CGM benefits for broad diabetes populationstat

Jun 8, 26Health workers at the epicenter of Congo’s Ebola outbreak labor with little pay or reststat

Jun 8, 26STAT+: AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trialsstat

Jun 8, 26City banks nearly $100M for next-gen RNAi drugsbiopharma dive

Jun 8, 26Incyte CEO sees $2B Vega deal aiding a post-Jakafi futureendpoints

Jun 8, 26Roche stakes $700M on Nurix’s protein-degrading drugbiopharma dive

Jun 8, 26Incyte to buy blood disorder drug in possibly $2B dealbiopharma dive

← prevpage 8 of 14next →